Authors: DEMARKWAHNEFRIED W HARS V CONAWAY MR HAVLIN K RIMER BK MCELVEEN G WINER EP

Citation: W. Demarkwahnefried et al., REDUCED RATES OF METABOLISM AND DECREASED PHYSICAL-ACTIVITY IN BREAST-CANCER PATIENTS RECEIVING ADJUVANT CHEMOTHERAPY, The American journal of clinical nutrition, 65(5), 1997, pp. 1495-1501

Authors: HAVLIN K

Citation: K. Havlin, A PHASE-I PHASE-II TRIAL OF GRANULOCYTE-COLONY-STIMULATING FACTOR AS BONE-MARROW SUPPORT IN PATIENTS TREATED WITH VINORELBINE (NAVELBINE) -STUDY DESIGN AND GOALS, Seminars in oncology, 22(2), 1995, pp. 38-40

Authors: ABELOFF MD",COLE,"VOGEL CL",HOHNEKER,"VOKES EE HORTOBAGYI GN",BURRIS,JONES,"FUMOLEAU P CHANG AY HAVLIN K

Citation: Ee. Abeloff Md",cole,"vogel Cl",hohneker,"vokes et al., ROUND-TABLE QUESTION AND ANSWER SESSION - DISCUSSION, Seminars in oncology, 22(2), 1995, pp. 41-44

Authors: OROURKE TJ BROWN TD HAVLIN K KUHN JG CRAIG JB BURRIS HA SATTERLEE WG TARASSOFF PG VONHOFF DD

Citation: Tj. Orourke et al., PHASE-I CLINICAL-TRIAL OF GEMCITABINE GIVEN AS AN INTRAVENOUS BOLUS ON 5 CONSECUTIVE DAYS, European journal of cancer, 30A(3), 1994, pp. 417-419

Authors: BROWN TD OROURKE TJ KUHN JG CRAIG JB HAVLIN K BURRIS HA CAGNOLA J HAMILTON JM GRINDEY GB SATTERLEE WG VONHOFF DD

Citation: Td. Brown et al., PHASE-I TRIAL OF SULOFENUR (LY186641) GIVEN ORALLY ON A DAILY X 21 SCHEDULE, Anti-cancer drugs, 5(2), 1994, pp. 151-159

Authors: RODRIGUEZ G BROWN TD BALIS FM CRAIG JB DENHAM CA KUHN JG HAVLIN K VONHOFF DD

Citation: G. Rodriguez et al., A PHASE-I TRIAL OF TRIMETREXATE (NSC352122) ON A DAILY X 5 SCHEDULE IN PATIENTS WITH REFRACTORY ADULT LEUKEMIA, Anti-cancer drugs, 4(2), 1993, pp. 163-166